1-1 of 1
R. Donald Harvey, Pharm, D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preliminary Results of a Phase I Study of the Pan-PI3 Kinase Inhibitor SF1126 in Patients with Relapsed and Refractory Myeloma.

Sagar Lonial, MD, R. Donald Harvey, Pharm, D., Dixil Francis, MPH, Engin Gul, Sundar Jagannath, MD, Sherif Farag, MBBS, PhD, Daniel Hoth, MD, Robert Frumento, M.S., MPH, Joseph R. Garlich, PhD, Suzanne Trudel, MD
Journal: Blood
Blood (2009) 114 (22): 3879.
https://doi.org/10.1182/blood.V114.22.3879.3879
Published: 2009